Three liabilities that close with the deal — and land on you.
A prior breach the target never reported.
OCR penalties and corrective-action plans follow the PHI, not the ownership change. You inherit an open liability the seller had every incentive not to disclose.
Years of undocumented HIPAA gaps.
Missing risk analyses, unencrypted PHI, and stale BAAs become your remediation cost the moment the deal closes — often mid-seven-figures at scale.
AI agents already in clinical workflows.
The target is deploying AI in scheduling, coding, and triage — ungoverned. Did your diligence cover which agents touch PHI, and under what authority? Almost none do.
Five domains. And what we find that auditors miss.
EHR / EMR security posture
What auditors miss: third-party integrations with standing PHI access no one has reviewed in years.
AI system governance
What auditors miss: AI agents making or influencing clinical decisions with no authorization trail.
HIPAA compliance gaps
What auditors miss: the required security risk analysis was never done — or is years out of date.
Integration risk (legacy → new)
What auditors miss: the merge itself opens attack paths as two networks are stitched together fast.
Incident history
What auditors miss: quiet prior incidents that were never disclosed — and the dwell-time evidence that they may still be active.
A due-diligence deliverable, on your deal timeline.
This is not a security audit — it's a diligence artifact scoped to a 2–4 week deal window, written for the people making the buy decision.
Request a Pre-Close Assessment →